Jun 01, 2021 / 02:30PM GMT
David Howard Windley - Jefferies LLC, Research Division - MD & Equity Analyst
Hi. Good morning, everybody. Dave Windley with Jefferies health care equity research here again. I cover the contract research and contract manufacturing space. And a leader in that space is Catalent, here to present next. Ticker, CTLT.
The management representatives here to talk to us about Catalent are CEO, John Chiminski; newly appointed CFO, Tom Castellano; and Paul Surdez, VP of IR. So we appreciate your attendance. Thanks so much for being here.
Questions and Answers:
David Howard Windley - Jefferies LLC, Research Division - MD & Equity AnalystI'm going to start, John, with you, just to talk about Catalent's come a long way in a year. Maybe talk about the journey you've been on and things that have kept you busy? And where you see Catalent competitively positioned at this point?
John R. Chiminski - Catalent, Inc. - Chairman & CEO
Yes. So thank you very much, Dave, and great to be here with you. First, I
Trustpilot
